SPI participated in the REGENERAR Project Meeting held at Hovione’s facilities in Lisbon on March 5–6, 2026. The meeting brought together more than 20 project members to review progress across all activities, discuss upcoming milestones, and coordinate next steps.
The REGENERAR project aims to develop a non-viral delivery formulation up to TRL4 for the delivery of a brain reprogramming formulation.
Within the project, SPI is responsible for communication, dissemination, and exploitation activities, as well as follow-up actions after the project’s lifetime.
SPI was represented by Susana Seabra, Taisiia Bondarenko and Eva Bernardino, who presented updates on ongoing communication and dissemination activities. Additionally, a dedicated exploitation session was organised to refine the project’s key results with strong potential for future application and impact.
